GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ribomic Inc (TSE:4591) » Definitions » Cyclically Adjusted Revenue per Share

Ribomic (TSE:4591) Cyclically Adjusted Revenue per Share : 円0.00 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Ribomic Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ribomic's adjusted revenue per share for the three months ended in Sep. 2024 was 円0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円0.00 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-04-25), Ribomic's current stock price is 円92.00. Ribomic's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was 円0.00. Ribomic's Cyclically Adjusted PS Ratio of today is .


Ribomic Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Ribomic's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ribomic Cyclically Adjusted Revenue per Share Chart

Ribomic Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ribomic Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ribomic's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Ribomic's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ribomic's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ribomic's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ribomic's Cyclically Adjusted PS Ratio falls into.


;
;

Ribomic Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ribomic's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0/108.9000*108.9000
=0.000

Current CPI (Sep. 2024) = 108.9000.

Ribomic Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 4.343 98.500 4.802
201412 3.754 97.900 4.176
201503 3.976 97.900 4.423
201506 3.055 98.400 3.381
201509 2.256 98.500 2.494
201512 2.048 98.100 2.273
201603 2.030 97.900 2.258
201606 1.895 98.100 2.104
201609 1.905 98.000 2.117
201612 1.882 98.400 2.083
201703 1.399 98.100 1.553
201706 1.345 98.500 1.487
201709 1.211 98.800 1.335
201712 1.207 99.400 1.322
201803 1.008 99.200 1.107
201806 0.000 99.200 0.000
201809 0.000 99.900 0.000
201812 0.000 99.700 0.000
201903 0.000 99.700 0.000
201906 0.127 99.800 0.139
201909 0.122 100.100 0.133
201912 0.120 100.500 0.130
202003 6.586 100.300 7.151
202006 0.110 99.900 0.120
202009 0.067 99.900 0.073
202012 0.067 99.300 0.073
202103 3.084 99.900 3.362
202106 0.090 99.500 0.099
202109 0.090 100.100 0.098
202112 0.088 100.100 0.096
202203 2.570 101.100 2.768
202206 0.088 101.800 0.094
202209 0.029 103.100 0.031
202212 0.000 104.100 0.000
202303 1.755 104.400 1.831
202306 0.000 105.200 0.000
202309 0.000 106.200 0.000
202312 0.000 106.800 0.000
202403 0.000 107.200 0.000
202409 0.000 108.900 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Ribomic  (TSE:4591) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ribomic Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Ribomic's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ribomic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ribomic Inc (TSE:4591) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
N/A
Address
3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.

Ribomic Headlines

No Headlines